Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

Cell | May 3, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12015982

To explore the role of c-Myc in carcinogenesis, we have developed a reversible transgenic model of pancreatic beta cell oncogenesis using a switchable form of the c-Myc protein. Activation of c-Myc in adult, mature beta cells induces uniform beta cell proliferation but is accompanied by overwhelming apoptosis that rapidly erodes beta cell mass. Thus, the oncogenic potential of c-Myc in beta cells is masked by apoptosis. Upon suppression of c-Myc-induced beta cell apoptosis by coexpression of Bcl-x(L), c-Myc triggers rapid and uniform progression into angiogenic, invasive tumors. Subsequent c-Myc deactivation induces rapid regression associated with vascular degeneration and beta cell apoptosis. Our data indicate that highly complex neoplastic lesions can be both induced and maintained in vivo by a simple combination of two interlocking molecular lesions.

Pubmed ID: 12015982 RIS Download

Mesh terms: 3T3 Cells | Animals | Apoptosis | Cadherins | Cell Division | Cell Line | Cell Nucleus | Estrogen Antagonists | Genes, myc | Humans | Insulinoma | Islets of Langerhans | Mice | Mice, Inbred Strains | Mice, Transgenic | Mutation | Pancreatic Neoplasms | Promoter Regions, Genetic | Proto-Oncogene Proteins c-bcl-2 | Proto-Oncogene Proteins c-myc | Receptors, Estrogen | Tamoxifen | bcl-X Protein

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.